Evidence of a local mechanism for desmopressin-induced tissue-type plasminogen activator release in human forearm

被引:41
作者
Wall, U [1 ]
Jern, S
Tengborn, L
Jern, C
机构
[1] Sahlgrens Univ Hosp, Dept Med, Clin Expt Res Lab, Heart & Lung Inst, S-41685 Gothenburg, Sweden
[2] Gothenburg Univ, Sahlgrens Univ Hosp, Dept Neurol, Inst Clin Neurosci, Gothenburg, Sweden
[3] Gothenburg Univ, Sahlgrens Univ Hosp, Inst Internal Med, Coagulat Ctr, Gothenburg, Sweden
关键词
D O I
10.1182/blood.V91.2.529.529_529_537
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic administration of desmopressin (DDAVP) induces increased plasma levels of tissue-type plasminogen activator (t-PA), coagulation factor VIII, and von Willebrand factor (VWF). However, the mechanisms behind these responses are not known. We tested the hypothesis that DDAVP acts as a local stimulator of acute endothelial release of t-PA and vWF independently of central pathways. Healthy, young, nonsmoking male volunteers were studied. In a first study (n = 7), DDAVP and placebo were administered as randomized single-blind stepwise intrabrachial artery infusions (0.7, 7.0, and 70 ng/min). In a another subset of subjects (n = 4), a constant-rate DDAVP infusion of 70 ng/min was administered for 20 minutes in the brachial artery of the nondominant arm with the dominant arm as control. To rule out that the observed t-PA release was flow-dependent, 4 additional subjects received stepwise intra-arterial infusions of both DDAVP (7.0, 21, and 70 ng/min) and sodium nitroprusside (SNP; 0.5, 2.5, and 10 mu g/min). Brachial venoarterial plasma concentration gradients and forearm plasma flow were used to determine net release/uptake rates of t-PA and vWF. At baseline, the average net release rate of t-PA was 6.7 ng/min across the whole forearm vascular bed, whereas there was no detectable basal release of vWF. Stepwise infusion of DDAVP induced a massive regulated release of t-PA with a peak after 15 minutes on the highest dose-step (ANOVA; P < .0001). The average maximum net release rate was 178 ng/min, and the total amount of t-PA released was, on the average, 3,000 ng. The majority was released in its active form. Constant-rate DDAVP infusion again markedly increased t-PA release in the infusion arm but had no effect whatsoever in the control arm. In contrast, DDAVP did not stimulate a local release of vWF in either study. Central hemodynamics were unchanged during infusions despite a local vasodilatory response with DDAVP. Endothelium-independent flow stimulation by SNP did not elicit any local t-PA release. We conclude that DDAVP induces a massive acute flow-independent release of t-PA, without the simultaneous release of vWF, in the human forearm vascular bed. The lack of a t-PA response in the control arm, as well as the unaltered central hemodynamics with DDAVP, confirms that the observed regulated t-PA release is local and independent of central mechanisms. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:529 / 537
页数:9
相关论文
共 47 条
[31]   DESIGN AND USES OF SELECTIVE AGONISTIC AND ANTAGONISTIC ANALOGS OF THE NEUROPEPTIDES OXYTOCIN AND VASOPRESSIN [J].
MANNING, M ;
SAWYER, WH .
TRENDS IN NEUROSCIENCES, 1984, 7 (01) :6-9
[32]   MECHANISM OF PLASMINOGEN ACTIVATOR AND FACTOR-VIII INCREASE AFTER VASOACTIVE DRUGS [J].
MANNUCCI, PM ;
ABERG, M ;
NILSSON, IM ;
ROBERTSON, B .
BRITISH JOURNAL OF HAEMATOLOGY, 1975, 30 (01) :81-93
[33]  
MAYADAS T, 1989, BLOOD, V73, P706
[34]   THE EFFECT OF DESAMINO-D-ARGININE VASOPRESSIN (DDAVP) AND NALOXONE INFUSIONS ON FACTOR-VIII AND POSSIBLE ENDOTHELIAL-CELL (EC) RELATED ACTIVITIES [J].
MOFFAT, EH ;
GIDDINGS, JC ;
BLOOM, AL .
BRITISH JOURNAL OF HAEMATOLOGY, 1984, 57 (04) :651-662
[35]  
NILSSON IM, 1980, SCAND J HAEMATOL, V24, P351
[36]   PHYSIOLOGIC AND PHARMACOLOGIC ENHANCEMENT OF FIBRINOLYSIS [J].
PROWSE, CV ;
CASH, JD .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1984, 10 (01) :51-60
[37]  
RANBY M, 1989, THROMB HAEMOSTASIS, V61, P409
[38]   Abnormal desmopressin-induced forearm vasodilatation in patients with heart failure: Dependence on nitric oxide synthase activity [J].
Rector, TS ;
Bank, AJ ;
Tschumperlin, LK ;
Mullen, KA ;
Lin, KA ;
Kubo, SH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (06) :667-674
[39]  
SMALLEY DM, 1993, THROMB HAEMOSTASIS, V70, P1043
[40]   VASODILATORY EFFECT OF ARGININE-VASOPRESSIN IS MEDIATED BY NITRIC-OXIDE IN HUMAN FOREARM VESSELS [J].
TAGAWA, T ;
IMAIZUMI, T ;
ENDO, T ;
SHIRAMOTO, M ;
HIROOKA, Y ;
ANDO, S ;
TAKESHITA, A .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (03) :1483-1490